Lymphosarcoma  >>  human allogeneic myeloid progenitor cells (CLT-008)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
human allogeneic myeloid progenitor cells (CLT-008) / Cellerant Therap
NCT00891137: Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Completed
1
30
US
human myeloid progenitor cells, CLT-008, hMPC
Cellerant Therapeutics, Department of Health and Human Services
Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes
06/14
06/14

Download Options